Latest News: Veeda Clinical raises $16 mn from Sabre partners Veeda Clinical Research acquires a majority stake in Bioneeds

Bioavailability & Bioequivalence

Bioavailability & Bioequivalence

Bioequivalence is the absence of a significant difference in the rate and extent of absorption of the active ingredient that reaches the systemic circulation (bioavailability). If products have equivalent bioavailability, it is considered they will have the same clinical effects. Bioequivalence studies follow well-defined procedures and are performed:

  • In a randomised, cross-over design
  • Where all subjects receive both test medicines separated by a washout period (inter-subject variability is eliminated)
  • To measure the rate and extent of absorption of the active ingredient in plasma
  • To compare the plasma concentration time curves

BA/BE Studies in Healthy Volunteers

BA/BE Studies in Healthy Volunteers

20 different dosage forms

  • Solid Oral Formulations (Tablets (Immediate Release & Modified Release e.g. ER, DR, SR), Capsules, Soft Gels, and Sprinkles etc.)
  • Parenteral Formulations
  • Topical Transdermal products (Patches, Cream, Ointments, Solutions)
  • Inhalation
  • Nasal and Oral Sprays
  • Rectal Products (Suppository & Foam)
  • Vaginal Products (Tablet, Cream, Gel)
  • Long Acting Injectable

Medical Writing Services

We have In-house experienced and highly trained medical writing professionals responsible for preparing the study documents in line applicable regulatory guidance and with the sponsor’s requirements.

  • Feasibility assessment
  • Protocol and it’s amendments
  • Informed Consent Documents
  • Case Report Form
  • Investigator’s brochure
  • Patient Diary
  • Clinical Study Reports

Project Management Services

Veeda Clinical Research Pvt Ltd, offers full service of managing the Clinical or Bio-equivalence studies from feasibility evaluation to clinical study report submission as per the protocol prescribed by the regulatory bodies and the protocol designed. Constant communication flow with sponsor, managing execution of pilot and pivotal bioequivalence studies including the preparation of product feasibility, Document finalization and regulatory services, interpreting pharmacokinetic & statistical bioequivalence results to clinical study report submission is a long and complex process. We have In-house experienced and highly trained project managers act as single point contact between Sponsor and Veeda. They play the lead role in planning, monitoring, controlling and closing projects.

Types of Studies

  • Conducted 3400+ Bioavailability & Bioequivalence Studies.
  • Experience of handling FTF&time-sensitive studies
  • Performed studies for injectable, rectal suppositories, Urine PK studies, Oral DDS, Local applications, Inhalations, etc
  • Short to Long residency Studies, Oral Inhalation - Pulmonary deposition & Therapeutic Equivalence Study, Pharmacokinetic interaction studies, Intravenous Anesthetic drug BE study (e.g. Propofol)&Glucose Clamp studies
  • Dose-Proportionality Studies&First-in-Human Studies (Phase-I trials)

Complex Studies (Glucose Clamp/ Inhalation/ Dermatology/ Suppository)

Glucose clamp

Veeda has an extensive experience in glucose clamp studies, a technique widely used to find novel ways of treating metabolic disorders such as diabetes, obesity, and fatty liver studies. The large number of glucose clamp studies carried out is testimony to the fact that Veeda has the clinical experience and professional expertise, thereby making us trusted partners for a number of national and international clients. Veeda’s commitment to data quality without jeopardizing participant well-being and safety is proof of the organization’s commitment to transparency, safety, and ethical conduct of clinical trials.

Inhalation

Inhalation

Inhalation products belong to topical drug delivery systems. They are delivered through pulmonary route. These studies require experienced staff, necessary infrastructure and extensive training to volunteers for standardize the dosing procedure. We understand your need. Veeda’s state of the art infrastructure and stable record of accomplishment with respect to regulatory compliance, quality, and ethics makes it a go-to CRO for perfect handling and execution of inhalation studies.

Suppository

Suppository

Veeda has an experience of conducting multiple studies with suppositories. Database of compliant volunteers with experience of previous participation in same type of studies. Trained and experienced staff with procedures to conduct dosing procedures.Clinics and pharmacy with controlled temperature and humidity to facilitate IMP handling.

Dermatology

Dermatology

Veeda has an experience of conducting Transdermal Patch Studies, Bioequivalence (BE) with pharmacokinetic (PK) endpoints and adhesion study, skin irritation and sensitization study (Proof of Procedure). A proof of procedure study for evaluation of skin irritation parameters, to identify the study challenges and also to evaluate cumulative skin irritation potential of test products (Control solutions) under occlusive patch conditions in healthy adult human subjects.

BA/BE Studies in Patients

Amalgamation of expertise and experience in Bioequivalence studies, Veeda provides best-in-class services to conduct Patient based Bioequivalence studies for various 505 B2 and complex generic products for our drug development clients. We have liaison with major hospitals and investigators’ to conduct patient PK studies and Clinical end point studies. We have colossal experience of conducting studies in all the major therapeutic areas, including Oncology, Psychiatry, Ophthalmology, Dermatology etc.

Pharmacokinetics (PK) Studies

With our wide range of services, we provide project planning to build quality into PK studies from the start – with risk mitigating strategies, efficient and effective time and budget planning, and optimizing the performance. Team has experience working with Risk Management Plan,Safety Management Plan,QA Audit Plan, IMP Plan,Data Management Plan,Edit check Plan,Monitoring Plan, Project Management Plan,PK sample management plan. The team is trained thoroughly to execute all these plans. Most importantly, the project managers are always prepared with a risk mitigation plan for the unforeseen conditions that may occur during a PK study.

Clinical end point studies

Our clinical end point studies monitoring services include study procedure development, source document review, patient eligibility confirmation, patient compliance tracking, supply inventory management, adverse events reporting, regulatory compliance monitoring and regulatory documentation maintenance. Project Managers provide solution-focused project management across our studies. They are a single point of contact, expertise in Therapeutic Equivalence studies. They provide meaningful insight into your recruitment challenges, evaluate the impact of competitive trials, and optimize patient access and retention. They provide accountability and transparency with a proven track record of successful delivery. Timelines and risks are managed proactively, applying knowledge from past experiences to ensure efficient study management.

We have vast database of Investigators and site associations to ensure rapid identification of potential investigators and their patient populations to help ensure enrolment goals are met. We also train investigators and site team on protocol requirements, Industry best practices and technology tools, such as electronic data capture.

Why Veeda?

  • Veeda is an Independent Indian CRO with 16 years of experience.
  • Veeda has conducted over 3400+ studies & has worked with over 200 (Bio) pharmaceutical companies around the world.
  • Veeda has an exemplary regulatory record of successfully completingaudits of USFDA, AGES, MHRA, ANVISA, WHO, NPA, ANSM, MCC, DCGI & NPRA
  • Due to stringent quality norms and transparency at all stages, Veeda is considered to be a preferred partner for many (Bio) Pharmaceutical companies
  • Veeda’s has a vast experience in scientific and regulatory compliant protocol designing that enables the drug development process of Early to Late phase clinical trials
  • Veeda has over 600+ analytical methods & 60+ NCE molecules developed and validated so far
  • Veeda ensures study specific clinical safety measures for all subjects through risk mitigation strategies
  • Veeda has Quality Management System in place to capture any non-compliance or deviation identified during the study with an effective mechanism of corrective and preventive actions implemented

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.